Kryger Capital’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Kryger Capital’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,284	Closed	-$2.14M	–	20
2024 Q1	$2.14M	Buy	+100,284	New	+$1.2M	0.4%	12

Kryger Capital's FUSN Position: Q2 2024 in Review

Kryger Capital sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 100,284 shares — an estimated $2.14M sold.

Kryger Capital first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $2.14M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Kryger Capital reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Kryger Capital sold 100,284 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.14M.
Kryger Capital first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Kryger Capital's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.14M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Kryger Capital's 13F filing for Q2 2024, filed 8 Aug 2024.